Skip to main navigation Skip to search Skip to main content

Thyroid carcinoma: Clinical practice guidelines

  • Steven I. Sherman
  • , Peter Angelos
  • , Douglas W. Ball
  • , Samuel W. Beenken
  • , David Byrd
  • , Orlo H. Clark
  • , Gilbert H. Daniels
  • , Raza A. Dilawari
  • , Hormoz Ehya
  • , William B. Farrar
  • , Robert F. Gagel
  • , Fouad Kandeel
  • , Richard T. Kloos
  • , Peter Kopp
  • , Dominick M. Lamonica
  • , Thom R. Loree
  • , William M. Lydiatt
  • , Judith McCaffrey
  • , John A. Olson
  • , John A. Ridge
  • Richard Robbins, Jatin P. Shah, James C. Sisson, Norman W. Thompson
  • University of Texas MD Anderson Cancer Center
  • Northwestern University
  • Johns Hopkins University
  • University of Alabama at Birmingham
  • University of Washington
  • University of California at San Francisco
  • Massachusetts General Hospital
  • Birjand University of Medical Sciences
  • Fox Chase Cancer Center
  • Ohio State University
  • City of Hope Cancer Center
  • Roswell Park Cancer Institute
  • Nebraska Medicine
  • Moffitt Cancer Center
  • Duke University
  • Memorial Sloan-Kettering Cancer Center
  • University of Michigan, Ann Arbor

Research output: Contribution to journalReview articlepeer-review

72 Scopus citations

Abstract

In 2005, approximately 1,490 cancer deaths will occur among persons living with thyroid carcinoma in the United States. Interestingly, although thyroid carcinoma occurs more often in women, mortality rates are higher for men, probably because men are usually older at the time of diagnosis. The incidence of thyroid carcinoma increased almost 240% between 1950 and 2000, but mortality rates decreased more than 44%. Although the causes of these statistically significant changes are uncertain, the increasing incidence may be caused by the increase in radiation-induced thyroid carcinoma. Conversely, the decrease in mortality may be related to earlier diagnosis, when the disease is presumably more amenable to intervention. However, this conclusion is confounded by a possible lead time bias.

Original languageEnglish
Pages (from-to)404-457
Number of pages54
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume3
Issue number3
DOIs
StatePublished - May 2005

Keywords

  • Anaplastic thyroid cancer
  • Cancer
  • Follicular cancer
  • Hürthle cell carcinoma
  • Malignancy
  • NCCN Clinical Practice Guidelines
  • Thyroid gland
  • Tumor

Fingerprint

Dive into the research topics of 'Thyroid carcinoma: Clinical practice guidelines'. Together they form a unique fingerprint.

Cite this